Pay in 4 interest-free payments of $7.13 Learn more
Ships within 48 hours · Estimated delivery Sep 2 - Sep 7
, (, )
Weight management, long-term (Saxenda) Mechanism: GLP-1 receptor agonist Dynamic interactions: Glucose lowering Kinetic interactions: Delayed gastric emptying, otherwise none in a bubble Liraglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist available as a once-daily subcutaneous injectable
As CEO Geoff Cook says: "Medication alone will not end the obesity epidemic
Patients should examine injection sites for lumps, indentations, redness, or tenderness
Certain GLP-1 drugs may not be recommended for people with a personal or family history of medullary thyroid carcinoma or multiple endocrine neoplasia syndrome type 2
US$ 21.53
US$ 21.52
US$ 28.65
US$ 20.68
US$ 25.59
US$ 24.16
